Modern production lines, expressive investments in equipment acquisition and maintenance enabled the company to monthly produce 15 million of packaged units. The manufacture process of the mix with about 240 medicines and more than 400 different presentations between the Farma, MIP (Over-the-counter products) Generic, and Hospital use lines was expanded through the improvement of world vanguard equipment.

Modern devices and strategic processes with intelligent flows guarantee greater productivity and eliminate idle capacity. Neo Química has invested on more than R$ 10 million (ten million reais) to upgrade and to make even more flexible the manufacturing plant. These procedures enabled the duplication of lotions, ointments, and penicillin products production. New investments will increase tablets and capsules production to 250 million /yearly.

To invest in technology that promotes quality and reliability is a constant procedure at Neo Química.